Search by property
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life + (The authors report no conflicts of interest)
- Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects + (The authors thank Dr. W. Schiess (Mucos Pharma, Geretsried) for his support in manuscript preparation.)
- Özdelikara et al. (2017): The Effect of Reflexology on Chemotherapy-induced Nausea, Vomiting, and Fatigue in Breast Cancer Patients + (There are no conflicts of interest.)
- Su et al. (2004): Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms + (Verum was donated by a commercial company)
- Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study + (Verum was donated to the RCT.)
- Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial + (Within the past three years, Dr. Khan has served as a consultant to Novartis Pharmaceutical Company, Inc. and Pfizer. Drs. Khan and Sharma have received during the past three years, via their institution)
- Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 + (“Employment or Leadership Position: None; Consultant or Advisory Role: David H. Johnson, Peloton Therapeutics (C), Mirna Therapeutics (C) Stock Ownership: None; Honoraria: None; research; Expert Testimony: None; Patents: None Other Remuneration: None“)
- Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial + („RM has had conference and travel expenses … „RM has had conference and travel expenses reimbursed and has received lecture fees from the pharmaceutical company biosyn-Arzneimittel GmbH, biosyn-Arzneimittel GmbH is not financing this manuscript. The other authors declare that they have no competing interests.“re that they have no competing interests.“)